Blake Brittain is a Reporter at Reuters. He covers a range of topics including intellectual property, litigation, and cybersecurity, with a keen interest in the intersection of law and technology, as well as arts and entertainment. Blake's work has been featured in notable publications such as iTNews Asia, Financial Post, and USA TODAY.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Blake Brittain's coverage focuses on legal and regulatory aspects in the technology industry, particularly related to copyright law, patent disputes, and import bans. He has a keen interest in covering legal battles involving major tech companies like Apple and patent disputes between pharmaceutical firms.
If you're reaching out to Blake with pitches or expertise, consider offering insights into legal implications of emerging technologies such as AI or potential impacts of copyright laws on specific industries. Additionally, if you have expert knowledge about ongoing patent disputes within the technology sector or the nuances of import ban regulations affecting tech products, it would be relevant for his coverage.
Given his focus on government announcements and legal policy regulation alongside specific technological themes like smartwatches and software & SaaS topics, keep these elements in mind when crafting your outreach to him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Blake Brittain
(Reuters) - A German-Canadian resident of China was sentenced to 24 months in prison in the U.S. for stealing electric vehicle trade secrets from Tesla for his competing EV battery business, the U.S. Department of Justice said on Monday.
Yum! Brands' KFC told a Texas federal court on Tuesday that it would end its lawsuit over rival fast-food chain Church's Texas Chicken's use of its trademarked phrase "Original Recipe" in advertising.
By Blake Brittain The U.S. International Trade Commission said on Tuesday that smartphones made by Lenovo's Motorola Mobility infringe
Amgen's leukemia drug Blincyto infringes patents owned by Germany's Lindis Biotech, a Delaware federal jury said in a verdict made public on Wednesday, awarding Lindis $50.3 million in damages.
By: Blake Brittain
By Blake Brittain Amgen's leukemia drug Blincyto infringes patents owned by Germany's Lindis Biotech, a Delaware federal jury said in a verdict made public on Wednesday, awarding Lindis $50.3...
A U.S. appeals court on Thursday upheld a $95.2 million jury verdict for tobacco giant Altria in a patent dispute with rival R.J. Reynolds [RIC:RIC:RAITH.UL] over e-cigarette technology.
A U.S. appeals court sided with PepsiCo on Thursday in a lawsuit from canned coffee maker Rise Brewing that accused Pepsi's "Mtn Dew Rise" morning energy drink of infringing its trademarks.
Teva Pharmaceuticals [RIC:RIC:TEVAN.UL] failed to convince a U.S. appeals court on Friday to reverse a decision that would remove patents related to its ProAir HFA inhaler from the U.S. Food and Drug Administration's Orange Book, which lists patents that protect drugs the FDA has deemed safe and effective.
By: Blake Brittain
Japanese drugmaker Nippon Shinyaku infringed a Sarepta patent related to its Duchenne muscular dystrophy (DMD) drug Vyondys 53 and must pay $115.2 million in damages, a Delaware jury said on Friday.
The new year may bring pivotal developments in a series of copyright lawsuits that could shape the future business of artificial intelligence.
(833) 317-6278 
